SOURCE: Xtalks

Xtalks Webinars

September 14, 2015 07:00 ET

The "Internet of Things" and Clinical Research: Privacy, Security, and Ethical Aspects, New Webinar Hosted by Xtalks

COLUMBIA, MD and TORONTO, ON--(Marketwired - September 14, 2015) - As part of its 2015 Advance Thought in Clinical Research series, Chesapeake IRB has invited a panel of esteemed speakers and industry experts to provide an important overview of impacts and issues involved in leveraging the "Internet of Things" within healthcare and clinical research. The live 90-minute broadcast takes place on Monday, September 28, 2015 at 11am EDT (4pm BST/ UK GMT +1).

The "Internet of Things" is a vision of the future where connected devices interact directly with other devices and database data, without any help from us. Its impact is already being felt as our ability to connect just about anything and gather attendant data grows at a dramatic rate. The Internet of Things (IoT) promises the power to transform healthcare, change how we detect and diagnose conditions, help create a larger pool of patients for clinical trials, speed enrollment, improve informed consent, and foster better care over the long run. It includes the combination of sensors, actuators, distributed computing power, and wireless communication on the hardware side, and applications and big data/analytics on the software side. The IoT is a cross-disciplinary effort involving sensor networking, data management and the internet.

The basic vision of IofT is that objects present in everyday life can be equipped with sensors which can track useful information. Attached to the internet, the information can flow through the same protocol that connects our computers to the internet. These uniquely identified internet-connected objects can sense whatever they are directed to, and communicate it -- enabling collection and analysis of data in an unprecedented flow and volume.

These objects simultaneously producing data in an automated way dwarf the amount of information which individuals can enter manually. Constrained by time, physical limits, inaccurate self-reporting, and transcription errors, humans simply cannot keep up. For example, sensor chips can be implanted in patients to capture vital signs and other data and wirelessly transmit it to central databases (including research databases for clinical trials). Proteus' smart ingestible pill can now monitor whether or not a patient has taken their medication and measure adherence. Consolidated with other patient health information, big data analytical algorithms monitor patient health in real-time. This is useful in automating monitoring of patients with heart or Alzheimer's conditions, and in assisted living, emergency response and health monitoring applications. It is revolutionary to clinical research, ethics and policy.

Enabling secure, remote real-time access to patient data is becoming increasingly critical. The IoT has become a meaningful opportunity for pharmaceutical companies to lower costs and accelerate clinical trials. It can help identify patients whose conditional are worsening or who are developing unexpected side effects, enabling earlier and more accurate detection of safety issues. Connected devices can identify patients with poor treatment adherence, ease logistics, and accelerate subject recruitment. Pharmaceutical companies and CROs have begun cutting cost and optimizing process with such connected devices and streamlined data collection tools, and leveraging collected data for concurrent use or future clinical trials.

Along with the potential advantages and benefits of the IoT, there are complexities and barriers to adoption. The data collected are so vast and often sensitive that its collection introduces new ethical considerations. The fact that this vast quantity data not only answers our questions but also organizes itself to reveal unanticipated important questions and correlations pushes the limits of current policy and requires us to examine regulation that could limit its potential. This program will provide an important overview of the impacts and issues involved in leveraging the IoT within healthcare and clinical research in particular.

Featured Speakers:

  • Eric Meslin, PhD, Director of the Indiana University Center for Bioethics, Dean for Bioethics, Indiana University School of Medicine
  • Jennifer Covich Bordenick, Co-Chair of the Federal HIT Policy Committee's Strategy and Innovation Workgroup, CEO of eHealth Initiative
  • Marvin Slepian, MD, Co-Founder and Chief Scientific Officer of SynCardia Systems Inc., Founder and Director of The Arizona Center for Accelerated Biomedical Innovation
  • Megan Doerr, MS, CGC, Principal Scientist, Governance Team, Sage Bionetworks
  • Ellen Kelso, Executive Director Strategic Development, Chesapeake IRB

To learn more or register for this event visit: The Internet of Things and Clinical Research

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2015/9/11/11G053757/Images/Chespeake_IRB_logo-397076345975.jpg

Contact Information